Lexaria Bioscience Corp (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste  rapidity  and delivery of bioactive compounds  including nicotine and cannabinoids To achieve higher absorption rates and fast onset  consumers traditionally defaulted to smoking